sr 2640 has been researched along with ablukast in 2 studies
| Studies (sr 2640) | Trials (sr 2640) | Recent Studies (post-2010) (sr 2640) | Studies (ablukast) | Trials (ablukast) | Recent Studies (post-2010) (ablukast) |
|---|---|---|---|---|---|
| 31 | 1 | 8 | 9 | 1 | 0 |
| Protein | Taxonomy | sr 2640 (IC50) | ablukast (IC50) |
|---|---|---|---|
| Thromboxane-A synthase | Homo sapiens (human) | 6 | |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krell, RD; Shaw, A | 1 |
| Brooks, CD; Summers, JB | 1 |
2 review(s) available for sr 2640 and ablukast
| Article | Year |
|---|---|
Peptide leukotrienes: current status of research.
Topics: Acetophenones; Humans; Leukotriene Antagonists; Leukotrienes; Molecular Structure; Peptides; Receptors, Immunologic; Receptors, Leukotriene; Tetrazoles | 1991 |
Modulators of leukotriene biosynthesis and receptor activation.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Carrier Proteins; Forecasting; Humans; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Molecular Structure; Receptors, Leukotriene | 1996 |